Preferences & Treatment Satisfaction Drivers in Rosacea Patients
Public ClinicalTrials.gov record NCT02602470. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.
Study identification
- NCT ID
- NCT02602470
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 206 participants
Conditions and interventions
Conditions
Interventions
- Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) Drug
- Azelaic Acid Cream Drug
- Metronidazole gel Drug
- Metronidazole cream Drug
- Metronidazole Emulsion Drug
- Metronidazole Lotion Drug
- Brimonidine Tartrate Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 7, 2015
- Primary completion
- Mar 9, 2016
- Completion
- Mar 9, 2016
- Last update posted
- Mar 31, 2020
2015 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Boston | Massachusetts | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Rosacea trials
Other public records listing Rosacea. Sorted by last update posted; newest first. Not a recommendation.
- NCT04108897: Analysis of the Microbiome in Rosacea Active, not recruiting
- NCT07600424: Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea: A Pilot Study Not yet recruiting
- NCT06312813: Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea Recruiting
- NCT06072066: Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea Recruiting
- NCT05942248: The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02602470, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2020 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02602470 live on ClinicalTrials.gov.